Viking Therapeutics Inc (NASDAQ:VKTX) Currently -207.87% Below Its 52-Week High, But There May Be A Surprise Downside

In last trading session, Viking Therapeutics Inc (NASDAQ:VKTX) saw 8.64 million shares changing hands with its beta currently measuring 0.87. Company’s recent per share price level of $32.29 trading at $3.03 or 10.36% at ring of the bell on the day assigns it a market valuation of $3.60B. That closing price of VKTX’s stock is at a discount of -207.87% from its 52-week high price of $99.41 and is indicating a premium of 11.3% from its 52-week low price of $28.64.

For Viking Therapeutics Inc (VKTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.12. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Viking Therapeutics Inc (NASDAQ:VKTX) trade information

Upright in the green during last session for gaining 10.36%, in the last five days VKTX remained trading in the green while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $32.29 price level, adding 6.05% to its value on the day. Viking Therapeutics Inc’s shares saw a change of -19.76% in year-to-date performance and have moved 7.78% in past 5-day. Viking Therapeutics Inc (NASDAQ:VKTX) showed a performance of -1.10% in past 30-days.

Wall Street analysts have assigned a consensus price target of 110 to the stock, which implies a rise of 70.65% to its current value. Analysts have been projecting 74 as a low price target for the stock while placing it at a high target of 110. It follows that stock’s current price would drop -129.17% in reaching the projected high whereas dropping to the targeted low would mean a loss of -129.17% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -23.00% during past 5 years.

Viking Therapeutics Inc (NASDAQ:VKTX)’s Major holders

FMR LLC is the top institutional holder at VKTX for having 16.54 million shares of worth $876.8 million. And as of 2024-06-30, it was holding 15.9876 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 10.1 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.7599 of outstanding shares, having a total worth of $535.26 million.

On the other hand, Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 3.78 shares of worth $122.07 million or 3.39% of the total outstanding shares. The later fund manager was in possession of 3.32 shares on Sep 30, 2024 , making its stake of worth around $107.35 million in the company or a holder of 2.98% of company’s stock.